tiprankstipranks
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
PremiumPress ReleasesSenti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
4M ago
Senti Bio announces FDA clearance of IND application for SENTI-202
PremiumThe Fly
Senti Bio announces FDA clearance of IND application for SENTI-202
4M ago
Senti Bio reports Q3 EPS (34c), consensus (44c)
PremiumThe Fly
Senti Bio reports Q3 EPS (34c), consensus (44c)
5M ago
Senti Bio to Participate in Upcoming Conferences
PremiumPress ReleasesSenti Bio to Participate in Upcoming Conferences
7M ago
Senti Bio to Participate in Upcoming Investor Conferences
PremiumPress Releases
Senti Bio to Participate in Upcoming Investor Conferences
8M ago
Senti Biosciences, Inc. (SNTI) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Senti Biosciences, Inc. (SNTI) Q2 Earnings Cheat Sheet
9M ago
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
PremiumPress ReleasesSenti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
11M ago
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
PremiumPress Releases
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
12M ago
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
PremiumPress Releases
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100